|
EIF2AK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.010800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.021780E-01 |
| Normal-vs-Stage2 |
1.996380E-01 |
| Normal-vs-Stage3 |
1.978180E-01 |
| Normal-vs-Stage4 |
2.653200E-01 |
| Stage1-vs-Stage2 |
9.639400E-01 |
| Stage1-vs-Stage3 |
2.402300E-02 |
| Stage1-vs-Stage4 |
8.913400E-01 |
| Stage2-vs-Stage3 |
3.571600E-02 |
| Stage2-vs-Stage4 |
8.501200E-01 |
| Stage3-vs-Stage4 |
1.360810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.939400E-01 |
| Normal-vs-AfricanAmerican |
4.881000E-01 |
| Normal-vs-Asian |
8.088800E-01 |
| Caucasian-vs-AfricanAmerican |
8.665400E-01 |
| Caucasian-vs-Asian |
7.882600E-01 |
| AfricanAmerican-vs-Asian |
8.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.154300E-02 |
| Normal-vs-Female |
1.844970E-01 |
| Male-vs-Female |
8.564400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.992000E-01 |
| Normal-vs-Extreme_Weight |
3.735600E-02 |
| Normal-vs-Obese |
8.136200E-01 |
| Normal-vs-Extreme_Obese |
9.986000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.826600E-01 |
| Normal_Weight-vs-Obese |
7.286600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.843600E-01 |
| Extreme_Weight-vs-Obese |
6.980500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.342600E-01 |
| Obese-vs-Extreme_Obese |
9.050000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.308000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.455400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.354400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.895600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.319000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.025600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.529240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.587900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.644000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.703600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.054370E-02 |
| Normal-VS-Type2 PRCC |
8.895000E-01 |
| Normal-VS-KIRP CIMP |
7.383800E-02 |
| Normal-VS-Unclassified PRCC |
6.896000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.429600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.548200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.981470E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.826100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.217000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.107800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.143000E-01 |
| Normal-vs-N1 |
4.526000E-01 |
| Normal-vs-N2 |
1.180630E-01 |
| N0-vs-N1 |
1.010580E-01 |
| N0-vs-N2 |
1.050570E-01 |
| N1-vs-N2 |
4.893000E-01 |
|
|
